<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1999-07-15" modified="2020-10-07" version="189">
<accession>Q64127</accession>
<accession>Q64126</accession>
<name>TIF1A_MOUSE</name>
<protein>
<recommendedName>
<fullName>Transcription intermediary factor 1-alpha</fullName>
<shortName>TIF1-alpha</shortName>
<ecNumber>2.3.2.27</ecNumber>
</recommendedName>
<alternativeName>
<fullName>E3 ubiquitin-protein ligase Trim24</fullName>
</alternativeName>
<alternativeName>
<fullName evidence="22">RING-type E3 ubiquitin transferase TIF1-alpha</fullName>
</alternativeName>
<alternativeName>
<fullName>Tripartite motif-containing protein 24</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">Trim24</name>
<name type="synonym">Tif1</name>
<name type="synonym">Tif1a</name>
</gene>
<organism>
<name type="scientific">Mus musculus</name>
<name type="common">Mouse</name>
<dbReference type="NCBI Taxonomy" id="10090"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Glires</taxon>
<taxon>Rodentia</taxon>
<taxon>Myomorpha</taxon>
<taxon>Muroidea</taxon>
<taxon>Muridae</taxon>
<taxon>Murinae</taxon>
<taxon>Mus</taxon>
<taxon>Mus</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1995" name="EMBO J." volume="14" first="2020" last="2033">
<title>The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18.</title>
<authorList>
<person name="le Douarin B."/>
<person name="Zechel C."/>
<person name="Garnier J.-M."/>
<person name="Lutz Y."/>
<person name="Tora L."/>
<person name="Pierrat B."/>
<person name="Heery D."/>
<person name="Gronemeyer H."/>
<person name="Chambon P."/>
<person name="Losson R."/>
</authorList>
<dbReference type="PubMed" id="7744009"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH ESTROGEN RECEPTOR</scope>
<scope>SUBCELLULAR LOCATION</scope>
<source>
<tissue>Carcinoma</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM LONG)</scope>
<source>
<strain>C57BL/6J</strain>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1996" name="EMBO J." volume="15" first="6701" last="6715">
<title>A possible involvement of TIF1 alpha and TIF1 beta in the epigenetic control of transcription by nuclear receptors.</title>
<authorList>
<person name="le Douarin B."/>
<person name="Nielsen A.L."/>
<person name="Garnier J.-M."/>
<person name="Ichinose H."/>
<person name="Jeanmougin F."/>
<person name="Losson R."/>
<person name="Chambon P."/>
</authorList>
<dbReference type="PubMed" id="8978696"/>
</citation>
<scope>INTERACTION WITH CBX1 AND CBX3</scope>
</reference>
<reference key="4">
<citation type="journal article" date="1999" name="Nat. Genet." volume="23" first="287" last="295">
<title>A RA-dependent, tumour-growth suppressive transcription complex is the target of the PML-RARalpha and T18 oncoproteins.</title>
<authorList>
<person name="Zhong S."/>
<person name="Delva L."/>
<person name="Rachez C."/>
<person name="Cenciarelli C."/>
<person name="Gandini D."/>
<person name="Zhang H."/>
<person name="Kalantry S."/>
<person name="Freedman L.P."/>
<person name="Pandolfi P.P."/>
</authorList>
<dbReference type="PubMed" id="10610177"/>
<dbReference type="DOI" id="10.1038/15463"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH PML</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2001" name="Mol. Cell. Biol." volume="21" first="3314" last="3324">
<title>Common properties of nuclear protein SP100 and TIF1alpha chromatin factor: role of SUMO modification.</title>
<authorList>
<person name="Seeler J.-S."/>
<person name="Marchio A."/>
<person name="Losson R."/>
<person name="Desterro J.M.P."/>
<person name="Hay R.T."/>
<person name="Chambon P."/>
<person name="Dejean A."/>
</authorList>
<dbReference type="PubMed" id="11313457"/>
<dbReference type="DOI" id="10.1128/mcb.21.10.3314-3324.2001"/>
</citation>
<scope>SUMOYLATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH CBX5</scope>
<scope>MUTAGENESIS OF LYS-724 AND LYS-742</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2006" name="J. Cell Biol." volume="174" first="329" last="338">
<title>Role of TIF1alpha as a modulator of embryonic transcription in the mouse zygote.</title>
<authorList>
<person name="Torres-Padilla M.E."/>
<person name="Zernicka-Goetz M."/>
</authorList>
<dbReference type="PubMed" id="16880268"/>
<dbReference type="DOI" id="10.1083/jcb.200603146"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2006" name="Mol. Endocrinol." volume="20" first="1276" last="1286">
<title>Transcriptional intermediary factor 1alpha mediates physical interaction and functional synergy between the coactivator-associated arginine methyltransferase 1 and glucocorticoid receptor-interacting protein 1 nuclear receptor coactivators.</title>
<authorList>
<person name="Teyssier C."/>
<person name="Ou C.Y."/>
<person name="Khetchoumian K."/>
<person name="Losson R."/>
<person name="Stallcup M.R."/>
</authorList>
<dbReference type="PubMed" id="16322096"/>
<dbReference type="DOI" id="10.1210/me.2005-0393"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH CARM1</scope>
<scope>IDENTIFICATION IN A COACTIVATOR COMPLEX WITH CARM1 AND NCOA2/GRIP1</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2007" name="Endocrinology" volume="148" first="3327" last="3337">
<title>Characterization of three growth hormone-responsive transcription factors preferentially expressed in adult female liver.</title>
<authorList>
<person name="Laz E.V."/>
<person name="Holloway M.G."/>
<person name="Chen C.S."/>
<person name="Waxman D.J."/>
</authorList>
<dbReference type="PubMed" id="17412818"/>
<dbReference type="DOI" id="10.1210/en.2006-1192"/>
</citation>
<scope>INDUCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2007" name="Nat. Genet." volume="39" first="1500" last="1506">
<title>Loss of Trim24 (Tif1alpha) gene function confers oncogenic activity to retinoic acid receptor alpha.</title>
<authorList>
<person name="Khetchoumian K."/>
<person name="Teletin M."/>
<person name="Tisserand J."/>
<person name="Mark M."/>
<person name="Herquel B."/>
<person name="Ignat M."/>
<person name="Zucman-Rossi J."/>
<person name="Cammas F."/>
<person name="Lerouge T."/>
<person name="Thibault C."/>
<person name="Metzger D."/>
<person name="Chambon P."/>
<person name="Losson R."/>
</authorList>
<dbReference type="PubMed" id="18026104"/>
<dbReference type="DOI" id="10.1038/ng.2007.15"/>
</citation>
<scope>DISRUPTION PHENOTYPE</scope>
<scope>FUNCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2007" name="Proc. Natl. Acad. Sci. U.S.A." volume="104" first="1488" last="1493">
<title>Large-scale phosphorylation analysis of mouse liver.</title>
<authorList>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Gerber S.A."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="17242355"/>
<dbReference type="DOI" id="10.1073/pnas.0609836104"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1026</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="11">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="2598" last="2603">
<title>Arterial calcifications and increased expression of vitamin D receptor targets in mice lacking TIF1alpha.</title>
<authorList>
<person name="Ignat M."/>
<person name="Teletin M."/>
<person name="Tisserand J."/>
<person name="Khetchoumian K."/>
<person name="Dennefeld C."/>
<person name="Chambon P."/>
<person name="Losson R."/>
<person name="Mark M."/>
</authorList>
<dbReference type="PubMed" id="18287084"/>
<dbReference type="DOI" id="10.1073/pnas.0712030105"/>
</citation>
<scope>DISRUPTION PHENOTYPE</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2009" name="Biochim. Biophys. Acta" volume="1793" first="1828" last="1836">
<title>TRIM24 mediates ligand-dependent activation of androgen receptor and is repressed by a bromodomain-containing protein, BRD7, in prostate cancer cells.</title>
<authorList>
<person name="Kikuchi M."/>
<person name="Okumura F."/>
<person name="Tsukiyama T."/>
<person name="Watanabe M."/>
<person name="Miyajima N."/>
<person name="Tanaka J."/>
<person name="Imamura M."/>
<person name="Hatakeyama S."/>
</authorList>
<dbReference type="PubMed" id="19909775"/>
<dbReference type="DOI" id="10.1016/j.bbamcr.2009.11.001"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH AR; KAT5/TIP60 AND BRD7</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2009" name="Proc. Natl. Acad. Sci. U.S.A." volume="106" first="11612" last="11616">
<title>Trim24 targets endogenous p53 for degradation.</title>
<authorList>
<person name="Allton K."/>
<person name="Jain A.K."/>
<person name="Herz H.M."/>
<person name="Tsai W.W."/>
<person name="Jung S.Y."/>
<person name="Qin J."/>
<person name="Bergmann A."/>
<person name="Johnson R.L."/>
<person name="Barton M.C."/>
</authorList>
<dbReference type="PubMed" id="19556538"/>
<dbReference type="DOI" id="10.1073/pnas.0813177106"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH TP53</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2010" name="Cell" volume="143" first="1174" last="1189">
<title>A tissue-specific atlas of mouse protein phosphorylation and expression.</title>
<authorList>
<person name="Huttlin E.L."/>
<person name="Jedrychowski M.P."/>
<person name="Elias J.E."/>
<person name="Goswami T."/>
<person name="Rad R."/>
<person name="Beausoleil S.A."/>
<person name="Villen J."/>
<person name="Haas W."/>
<person name="Sowa M.E."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="21183079"/>
<dbReference type="DOI" id="10.1016/j.cell.2010.12.001"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-661; SER-668; SER-812 AND SER-1026</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Brain</tissue>
<tissue>Kidney</tissue>
<tissue>Liver</tissue>
<tissue>Lung</tissue>
<tissue>Pancreas</tissue>
<tissue>Spleen</tissue>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="15">
<citation type="journal article" date="2014" name="Mol. Cell. Proteomics" volume="13" first="372" last="387">
<title>Immunoaffinity enrichment and mass spectrometry analysis of protein methylation.</title>
<authorList>
<person name="Guo A."/>
<person name="Gu H."/>
<person name="Zhou J."/>
<person name="Mulhern D."/>
<person name="Wang Y."/>
<person name="Lee K.A."/>
<person name="Yang V."/>
<person name="Aguiar M."/>
<person name="Kornhauser J."/>
<person name="Jia X."/>
<person name="Ren J."/>
<person name="Beausoleil S.A."/>
<person name="Silva J.C."/>
<person name="Vemulapalli V."/>
<person name="Bedford M.T."/>
<person name="Comb M.J."/>
</authorList>
<dbReference type="PubMed" id="24129315"/>
<dbReference type="DOI" id="10.1074/mcp.o113.027870"/>
</citation>
<scope>METHYLATION [LARGE SCALE ANALYSIS] AT ARG-469</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Embryo</tissue>
</source>
</reference>
<comment type="function">
<text evidence="4 11 13 14 16 18 19 20">Transcriptional coactivator that interacts with numerous nuclear receptors and coactivators and modulates the transcription of target genes. Interacts with chromatin depending on histone H3 modifications, having the highest affinity for histone H3 that is both unmodified at 'Lys-4' (H3K4me0) and acetylated at 'Lys-23' (H3K23ac) (By similarity). Has E3 protein-ubiquitin ligase activity. Promotes ubiquitination and proteasomal degradation of p53/TP53. Plays a role in the regulation of cell proliferation and apoptosis via its effects on p53/TP53 levels. Up-regulates ligand-dependent transcription activation by AR, GCR/NR3C1, thyroid hormone receptor (TR) and ESR1. Modulates transcription activation by retinoic acid (RA) receptors, such as RARA. Plays a role in regulating retinoic acid-dependent proliferation of hepatocytes. Required for normal transition from proliferating neonatal hepatocytes to quiescent adult hepatocytes.</text>
</comment>
<comment type="catalytic activity">
<reaction>
<text>S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.</text>
<dbReference type="EC" id="2.3.2.27"/>
</reaction>
</comment>
<comment type="pathway">
<text>Protein modification; protein ubiquitination.</text>
</comment>
<comment type="subunit">
<text evidence="4 11 12 13 18 19 20 21">Interacts (via bromo domain) with histone H3 (via N-terminus), provided that it is not methylated at 'Lys-4' (H3K4me0). Does not interact with histone H3 that is methylated at 'Lys-4' (H3K4me1, H3K4me2 or H3K4me3). Interacts (via bromo domain) with histone H3 (via N-terminus) that is acetylated at 'Lys-23' (H3K23ac). Has the highest affinity for histone H3 that is both unmodified at 'Lys-4' (H3K4me0) and acetylated at 'Lys-23' (H3K23ac). Has very low affinity for histone H3 that is methylated at 'Lys-9' (H3K9me), or acetylated at both 'Lys-9' (H3K9ac) and 'Lys-14' (H3K14ac), or acetylated at 'Lys-27' (H3K27ac) (in vitro). Interacts with TRIM16. Interacts with NR3C2/MCR (By similarity). Interacts with the ligand-binding domain of estrogen receptors (in vitro). Interaction with DNA-bound estrogen receptors requires the presence of estradiol (By similarity). Interacts with AR, CARM1, KAT5/TIP60, NCOA2/GRIP1, BRD7, CBX1, CBX3 and CBX5. Part of a coactivator complex containing TRIM24, NCOA2/GRIP1 and CARM1. Interacts with p53/TP53 and PML.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-307947">
<id>Q64127</id>
</interactant>
<interactant intactId="EBI-78119">
<id>P83917</id>
<label>Cbx1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-307947">
<id>Q64127</id>
</interactant>
<interactant intactId="EBI-307973">
<id>Q61686</id>
<label>Cbx5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-307947">
<id>Q64127</id>
</interactant>
<interactant intactId="EBI-474016">
<id>P02340</id>
<label>Tp53</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-307947">
<id>Q64127</id>
</interactant>
<interactant intactId="EBI-3043980">
<id>Q99PP7</id>
<label>Trim33</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<text>Detected in the cytoplasm of the zygote. Translocates into the pronucleus at the time of genome activation. Colocalizes with sites of active transcription.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q64127-1</id>
<name>Long</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q64127-2</id>
<name>Short</name>
<sequence type="described" ref="VSP_005773"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="15 16">Detected in embryonic and adult liver. Detected in zygote and throughout embryogenesis (at protein level). Detected in all adult tissues, with the highest expression level in testis.</text>
</comment>
<comment type="induction">
<text evidence="15">Before puberty, highly expressed in liver from males and females. After puberty, expression is considerably higher in liver from females compared to males. Up-regulated in males by continuous exposure to growth hormone.</text>
</comment>
<comment type="PTM">
<text evidence="12">Sumoylated.</text>
</comment>
<comment type="disease">
<text>A chromosomal aberration involving TRIM24 produces a TRIM24-BRAF (T18) oncogene originally isolated from a furfural-induced hepatoma.</text>
</comment>
<comment type="disruption phenotype">
<text evidence="16 17">No visible phenotype during the first few months. Impaired transition from proliferating neonatal hepatocytes to quiescent adult hepatocytes. Hepatocytes continue to proliferate throughout adulthood. High incidence hypertrophic hepatocytes with enlarged nuclei after three months. After nine months, about half of the mice have hepatocellular adenomas. Very high incidence of hepatocarcinoma in 13 to 29 month old mice, increasing from 40% to 80%. When one copy of Rara is disrupted, mice do not develop liver tumors or liver dysplasia.</text>
</comment>
<dbReference type="EC" id="2.3.2.27"/>
<dbReference type="EMBL" id="S78221">
<property type="protein sequence ID" value="AAB34290.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="S78219">
<property type="protein sequence ID" value="AAB34289.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC056959">
<property type="protein sequence ID" value="AAH56959.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS20008.1">
<molecule id="Q64127-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS71751.1">
<molecule id="Q64127-2"/>
</dbReference>
<dbReference type="PIR" id="S55259">
<property type="entry name" value="S55259"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001258993.1">
<molecule id="Q64127-2"/>
<property type="nucleotide sequence ID" value="NM_001272064.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001259005.1">
<property type="nucleotide sequence ID" value="NM_001272076.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_659542.3">
<molecule id="Q64127-1"/>
<property type="nucleotide sequence ID" value="NM_145076.4"/>
</dbReference>
<dbReference type="SMR" id="Q64127"/>
<dbReference type="BioGRID" id="204196">
<property type="interactions" value="16"/>
</dbReference>
<dbReference type="DIP" id="DIP-31476N"/>
<dbReference type="IntAct" id="Q64127">
<property type="interactions" value="13"/>
</dbReference>
<dbReference type="MINT" id="Q64127"/>
<dbReference type="STRING" id="10090.ENSMUSP00000031859"/>
<dbReference type="iPTMnet" id="Q64127"/>
<dbReference type="PhosphoSitePlus" id="Q64127"/>
<dbReference type="EPD" id="Q64127"/>
<dbReference type="jPOST" id="Q64127"/>
<dbReference type="PaxDb" id="Q64127"/>
<dbReference type="PeptideAtlas" id="Q64127"/>
<dbReference type="PRIDE" id="Q64127"/>
<dbReference type="Antibodypedia" id="32326">
<property type="antibodies" value="505 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENSMUST00000031859">
<molecule id="Q64127-1"/>
<property type="protein sequence ID" value="ENSMUSP00000031859"/>
<property type="gene ID" value="ENSMUSG00000029833"/>
</dbReference>
<dbReference type="Ensembl" id="ENSMUST00000120428">
<molecule id="Q64127-2"/>
<property type="protein sequence ID" value="ENSMUSP00000113063"/>
<property type="gene ID" value="ENSMUSG00000029833"/>
</dbReference>
<dbReference type="GeneID" id="21848"/>
<dbReference type="KEGG" id="mmu:21848"/>
<dbReference type="UCSC" id="uc009bjk.2">
<molecule id="Q64127-1"/>
<property type="organism name" value="mouse"/>
</dbReference>
<dbReference type="UCSC" id="uc009bjl.2">
<molecule id="Q64127-2"/>
<property type="organism name" value="mouse"/>
</dbReference>
<dbReference type="CTD" id="8805"/>
<dbReference type="MGI" id="MGI:109275">
<property type="gene designation" value="Trim24"/>
</dbReference>
<dbReference type="eggNOG" id="KOG2177">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000159863"/>
<dbReference type="HOGENOM" id="CLU_005817_0_1_1"/>
<dbReference type="InParanoid" id="Q64127"/>
<dbReference type="KO" id="K08881"/>
<dbReference type="OMA" id="VCMSCDD"/>
<dbReference type="OrthoDB" id="756911at2759"/>
<dbReference type="PhylomeDB" id="Q64127"/>
<dbReference type="TreeFam" id="TF106455"/>
<dbReference type="UniPathway" id="UPA00143"/>
<dbReference type="BioGRID-ORCS" id="21848">
<property type="hits" value="4 hits in 22 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="Trim24">
<property type="organism name" value="mouse"/>
</dbReference>
<dbReference type="PRO" id="PR:Q64127"/>
<dbReference type="Proteomes" id="UP000000589">
<property type="component" value="Chromosome 6"/>
</dbReference>
<dbReference type="RNAct" id="Q64127">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSMUSG00000029833">
<property type="expression patterns" value="Expressed in testis and 323 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q64127">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q64127">
<property type="organism ID" value="MM"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0005719">
<property type="term" value="C:nuclear euchromatin"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005726">
<property type="term" value="C:perichromatin fibrils"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0003682">
<property type="term" value="F:chromatin binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0034056">
<property type="term" value="F:estrogen response element binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070577">
<property type="term" value="F:lysine-acetylated histone binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016922">
<property type="term" value="F:nuclear receptor binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0002039">
<property type="term" value="F:p53 binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004672">
<property type="term" value="F:protein kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0043565">
<property type="term" value="F:sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0003713">
<property type="term" value="F:transcription coactivator activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0061630">
<property type="term" value="F:ubiquitin protein ligase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0004842">
<property type="term" value="F:ubiquitin-protein transferase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008270">
<property type="term" value="F:zinc ion binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0055074">
<property type="term" value="P:calcium ion homeostasis"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0071391">
<property type="term" value="P:cellular response to estrogen stimulus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008285">
<property type="term" value="P:negative regulation of cell population proliferation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0045892">
<property type="term" value="P:negative regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0010628">
<property type="term" value="P:positive regulation of gene expression"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0046777">
<property type="term" value="P:protein autophosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0030163">
<property type="term" value="P:protein catabolic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006468">
<property type="term" value="P:protein phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0016567">
<property type="term" value="P:protein ubiquitination"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042981">
<property type="term" value="P:regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000266"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0031647">
<property type="term" value="P:regulation of protein stability"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1901796">
<property type="term" value="P:regulation of signal transduction by p53 class mediator"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0070562">
<property type="term" value="P:regulation of vitamin D receptor signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="CDD" id="cd00021">
<property type="entry name" value="BBOX"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="1.20.920.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR003649">
<property type="entry name" value="Bbox_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR001487">
<property type="entry name" value="Bromodomain"/>
</dbReference>
<dbReference type="InterPro" id="IPR036427">
<property type="entry name" value="Bromodomain-like_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR018359">
<property type="entry name" value="Bromodomain_CS"/>
</dbReference>
<dbReference type="InterPro" id="IPR019786">
<property type="entry name" value="Zinc_finger_PHD-type_CS"/>
</dbReference>
<dbReference type="InterPro" id="IPR000315">
<property type="entry name" value="Znf_B-box"/>
</dbReference>
<dbReference type="InterPro" id="IPR011011">
<property type="entry name" value="Znf_FYVE_PHD"/>
</dbReference>
<dbReference type="InterPro" id="IPR001965">
<property type="entry name" value="Znf_PHD"/>
</dbReference>
<dbReference type="InterPro" id="IPR019787">
<property type="entry name" value="Znf_PHD-finger"/>
</dbReference>
<dbReference type="InterPro" id="IPR001841">
<property type="entry name" value="Znf_RING"/>
</dbReference>
<dbReference type="InterPro" id="IPR017907">
<property type="entry name" value="Znf_RING_CS"/>
</dbReference>
<dbReference type="Pfam" id="PF00439">
<property type="entry name" value="Bromodomain"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00628">
<property type="entry name" value="PHD"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00643">
<property type="entry name" value="zf-B_box"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00503">
<property type="entry name" value="BROMODOMAIN"/>
</dbReference>
<dbReference type="SMART" id="SM00502">
<property type="entry name" value="BBC"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00336">
<property type="entry name" value="BBOX"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SMART" id="SM00297">
<property type="entry name" value="BROMO"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00249">
<property type="entry name" value="PHD"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00184">
<property type="entry name" value="RING"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF47370">
<property type="entry name" value="SSF47370"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF57903">
<property type="entry name" value="SSF57903"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00633">
<property type="entry name" value="BROMODOMAIN_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50014">
<property type="entry name" value="BROMODOMAIN_2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50119">
<property type="entry name" value="ZF_BBOX"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS01359">
<property type="entry name" value="ZF_PHD_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50016">
<property type="entry name" value="ZF_PHD_2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00518">
<property type="entry name" value="ZF_RING_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50089">
<property type="entry name" value="ZF_RING_2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0103">Bromodomain</keyword>
<keyword id="KW-0160">Chromosomal rearrangement</keyword>
<keyword id="KW-0175">Coiled coil</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0656">Proto-oncogene</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0678">Repressor</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0043">Tumor suppressor</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<keyword id="KW-0833">Ubl conjugation pathway</keyword>
<keyword id="KW-0862">Zinc</keyword>
<keyword id="KW-0863">Zinc-finger</keyword>
<feature type="chain" description="Transcription intermediary factor 1-alpha" id="PRO_0000056391">
<location>
<begin position="1"/>
<end position="1051"/>
</location>
</feature>
<feature type="domain" description="Bromo" evidence="8">
<location>
<begin position="933"/>
<end position="988"/>
</location>
</feature>
<feature type="zinc finger region" description="RING-type" evidence="10">
<location>
<begin position="52"/>
<end position="77"/>
</location>
</feature>
<feature type="zinc finger region" description="B box-type 1" evidence="7">
<location>
<begin position="158"/>
<end position="211"/>
</location>
</feature>
<feature type="zinc finger region" description="B box-type 2" evidence="7">
<location>
<begin position="218"/>
<end position="259"/>
</location>
</feature>
<feature type="zinc finger region" description="PHD-type" evidence="9">
<location>
<begin position="827"/>
<end position="874"/>
</location>
</feature>
<feature type="region of interest" description="Nuclear receptor binding site (NRBS)">
<location>
<begin position="755"/>
<end position="780"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with histone H3 that is not methylated at 'Lys-4' (H3K4me0)" evidence="4">
<location>
<begin position="835"/>
<end position="841"/>
</location>
</feature>
<feature type="coiled-coil region" evidence="6">
<location>
<begin position="289"/>
<end position="359"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear localization signal" evidence="6">
<location>
<begin position="892"/>
<end position="908"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Ala">
<location>
<begin position="8"/>
<end position="15"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Ala">
<location>
<begin position="19"/>
<end position="22"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Gln">
<location>
<begin position="344"/>
<end position="347"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Ser">
<location>
<begin position="583"/>
<end position="587"/>
</location>
</feature>
<feature type="site" description="Breakpoint for translocation to form TRIM24-BRAF oncogene">
<location>
<begin position="332"/>
<end position="333"/>
</location>
</feature>
<feature type="site" description="Interaction with histone H3 that is not methylated at 'Lys-4' (H3K4me0)" evidence="4">
<location>
<position position="828"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="5">
<location>
<position position="97"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5">
<location>
<position position="110"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine" evidence="3">
<location>
<position position="469"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5">
<location>
<position position="655"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2">
<location>
<position position="661"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2">
<location>
<position position="668"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5">
<location>
<position position="745"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5">
<location>
<position position="769"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5">
<location>
<position position="809"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2">
<location>
<position position="812"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="5">
<location>
<position position="819"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1 2">
<location>
<position position="1026"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5">
<location>
<position position="1029"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5">
<location>
<position position="1043"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="5">
<location>
<position position="7"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="5">
<location>
<position position="205"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="5">
<location>
<position position="276"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="5">
<location>
<position position="436"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="5">
<location>
<position position="458"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="5">
<location>
<position position="553"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="5">
<location>
<position position="642"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="5">
<location>
<position position="703"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="5">
<location>
<position position="712"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate" evidence="22">
<location>
<position position="724"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate" evidence="5">
<location>
<position position="724"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="5">
<location>
<position position="724"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate" evidence="22">
<location>
<position position="742"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="5">
<location>
<position position="742"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="5">
<location>
<position position="802"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="5">
<location>
<position position="811"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="5">
<location>
<position position="876"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="5">
<location>
<position position="950"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="5">
<location>
<position position="993"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="5">
<location>
<position position="1042"/>
</location>
</feature>
<feature type="splice variant" description="In isoform Short." id="VSP_005773" evidence="22">
<location>
<begin position="477"/>
<end position="510"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of sumoylation; when associated with R-742." evidence="12">
<original>K</original>
<variation>R</variation>
<location>
<position position="724"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of sumoylation; when associated with R-724." evidence="12">
<original>K</original>
<variation>R</variation>
<location>
<position position="742"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17242355"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21183079"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24129315"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000250"/>
<evidence key="5" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="O15164"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000255"/>
<evidence key="7" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00024"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00035"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00146"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00175"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10610177"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11313457"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16322096"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16880268"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17412818"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18026104"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18287084"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19556538"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19909775"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7744009"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8978696"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000305"/>
<sequence length="1051" mass="116657" checksum="610584C1C6885972" modified="1996-11-01" version="1">MEVAVEKAAAAAAPAGGPAAAAPSGENEAESRQGPDSESGGEASRLNLLDTCAVCHQNIQSRVPKLLPCLHSFCQRCLPAPQRYLMLTAPALGSAETPPPAPAPAPAPGSPAGGPSPFATQVGVIRCPVCSQECAERHIIDNFFVKDTTEVPSSTVEKSNQVCTSCEDNAEANGFCVECVEWLCKTCIRAHQRVKFTKDHTVRQKEEVSPEAVGVTSQRPVFCPFHKKEQLKLYCETCDKLTCRDCQLLEHKEHRYQFIEEAFQNQKVIIDTLITKLMEKTKYIKYTGNQIQNRIIEINQNQKQVEQDIKVAIFTLMVEINKKGKALLHQLESLAKDHRMKLMQQQQEVAGLSKQLEHVMHFSKWAVSSGSSTALLYSKRLITYRLRHLLRARCDASPVTNTTIQFHCDPSFWAQNIINLGSLVIEDKESQPQMPKQNPVVEQSSQPPGGLPSNQLSKFPTQISLAQLRLQHIQQQVMAQRQQVQRRPAPVGLPNPRMQGPIQQPSISHQHPPPRLINFQNHSPKPNGPVLPPYPQQLRYSPSQNVPRQTTIKPNPLQMAFLAQQAIKQWQISSVQAPPTTASSSSSTPSSPTITSAAGYDGKAFSSPMIDLSAPVGGSYNLPSLPDIDCSSTIMLDNIARKDTGVDHAQPRPPSNRTVQSPNSSVPSPGLAGPVTMTSVHPPIRSPSASSVGSRGSSGSSSKPAGADSTHKVPVVMLEPIRIKQENSGPPENYDFPVVIVKQESDEESRPQNTNYPRSILTSLLLNSSQSSASEETVLRSDAPDSTGDQPGLHQENSSNGKSEWSDASQKSPVHVGETRKEDDPNEDWCAVCQNGGELLCCEKCPKVFHLTCHVPTLTNFPSGEWICTFCRDLSKPEVDYDCDVPSHHSEKRKSEGLTKLTPIDKRKCERLLLFLYCHEMSLAFQDPVPLTVPDYYKIIKNPMDLSTIKKRLQEDYCMYTKPEDFVADFRLIFQNCAEFNEPDSEVANAGIKLESYFEELLKNLYPEKRFPKVEFRHEAEDCKFSDDSDDDFVQPRKKRLKSTEDRQLLK</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

